Oisín Biotechnologies
Organisation
People
Head of Preclinical Manufacturing
Head of Aging R&D
Chief Operating Officer
Chief Science Officer
Chief Executive Officer
Sources: oisinbio.com
Board
Board director, Chief Executive Officer, Methuselah Foundation
Board director, Managing Director, AbbVie Ventures
Chairman
Board director
Sources: oisinbio.com
Funding rounds
Series A
US$15m, 24 Jul 2024
Sources: news.google.com
Named in competing interests
Integrative Omics Reveal Female-Specific Benefits of p16+ Cell Clearance in Aging Mice
Consulting or advice, 30 Oct 2025
The senescence-associated secretory phenotype and its physiological and pathological implications
Consulting or advice, 23 Apr 2024
Sources: pubmed.ncbi.nlm.nih.gov
Competes in
Sources: oisinbio.com